Health and Fitness Health and Fitness
Wed, October 19, 2011
[ Wed, Oct 19th 2011 ] - Market Wire
Notice of AGM

Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th


Published on 2011-10-19 03:23:08 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery, development and commercialization of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., chairman and chief executive officer, will present at the 10th Annual BIO Investor Forum on Wednesday, October 26th in San Francisco.

The Company's presentation will begin at 1:30 p.m. PT. A live webcast of the presentation will be available in the Investor Events section of the Company's website, [ www.astx.com ]. The webcast will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. The Company is developing a proprietary pipeline of novel cancer therapeutics, will selectively in-license assets possessing a strategic fit with an attractive cost a" value ratio, and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals, formerly SuperGen, developed Dacogen® and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit [ http://www.astx.com ].